SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056929
Filing Date
2024-05-09
Accepted
2024-05-09 16:08:41
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q achv-20240331.htm   iXBRL 10-Q 1629327
2 EX-31.1 achv-ex31_1.htm EX-31.1 10456
3 EX-32.1 achv-ex32_1.htm EX-32.1 5819
  Complete submission text file 0000950170-24-056929.txt   6846197

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT achv-20240331.xsd EX-101.SCH 1188916
64 EXTRACTED XBRL INSTANCE DOCUMENT achv-20240331_htm.xml XML 1051693
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 24930581
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)